High Outlier
DEA Schedule CIII
Strength
105 mg/1
Manufacturer
Acertis Pharmaceuticals, LLCNDC
72989040930
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PHENDIMETRAZINE TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA018074On Market Since
11/1/2022
Pharmacological Classes
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203003•Taro Pharmaceuticals U.S.A. Inc.
$0.0678
per ML
PHENTERMINE 37.5 MG TABLET
Generic
10702002501•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
10702002510•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016001•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016003•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016030•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
43547040410•Solco Healthcare US LLC
$0.0694
per EA